<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.4: Precision Supplementation & Micronutrient Synergy</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Advanced Deep Dives */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Text Styles */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f8f9fa;
            color: #1e3a8a;
            font-weight: 600;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
            font-weight: 600;
            text-transform: uppercase;
            font-size: 12px;
            letter-spacing: 1px;
            margin-bottom: 8px;
            display: block;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* References & Footer */
        .references-box {
            background: #f9f9f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
        }

        .takeaways-box {
            background: #1e3a8a;
            color: white;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            margin-bottom: 15px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Metabolic Deep Dives</p>
            <h1 class="lesson-title">Lesson 8.4: Precision Supplementation & Micronutrient Synergy</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#berberine"><span class="section-num">1</span>Berberine & AMPK Pathways</a></li>
                <li><a href="#neuropathy"><span class="section-num">2</span>ALA & Benfotiamine Protocols</a></li>
                <li><a href="#magnesium"><span class="section-num">3</span>The Magnesium-Insulin Axis</a></li>
                <li><a href="#pancreas"><span class="section-num">4</span>Pancreatic Islet Co-factors</a></li>
                <li><a href="#interactions"><span class="section-num">5</span>Supplement-Drug Interactions</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the molecular mechanics of Berberine and its pharmaceutical equivalence to Metformin.</li>
                <li>Design evidence-based protocols for mitigating diabetic neuropathy using ALA and Benfotiamine.</li>
                <li>Explain the critical role of intracellular magnesium in Tyrosine Kinase activity.</li>
                <li>Evaluate the synergy of Vitamin D3, K2, and Zinc in insulin synthesis and secretion.</li>
                <li>Navigate complex contraindications between therapeutic supplements and common diabetic medications.</li>
            </ul>
        </div>

        <h2 id="berberine">1. Berberine: The AMPK Master Switch</h2>
        <p>In the hierarchy of blood sugar botanical interventions, <span class="highlight">Berberine</span> stands alone. An isoquinoline alkaloid found in plants like <i>Berberis aristata</i>, its primary mechanism of action mimics the cornerstone pharmaceutical Metformin: the activation of <strong>Adenosine Monophosphate-activated Protein Kinase (AMPK)</strong>.</p>

        <p>AMPK is often described as the "metabolic master switch." When activated, it shifts the cell from an anabolic (storage) state to a catabolic (burning) state. A 2014 meta-analysis of 27 randomized controlled trials (n=2,569) published in the <i>Journal of Ethnopharmacology</i> demonstrated that Berberine combined with lifestyle changes was <span class="stat-highlight">equally effective as Metformin</span> in reducing HbA1c, fasting blood glucose, and postprandial glucose.</p>

        <div class="alert-box info">
            <p><strong>The Molecular Mechanism:</strong> Berberine inhibits Complex I of the mitochondrial respiratory chain. This increases the AMP:ATP ratio, which triggers AMPK. Once active, AMPK promotes GLUT4 translocation to the cell membrane, allowing glucose entry into the muscle independent of insulin signaling.</p>
        </div>

        <h2 id="neuropathy">2. Mitigating Neuropathy: ALA & Benfotiamine</h2>
        <p>Diabetic peripheral neuropathy (DPN) affects approximately <span class="stat-highlight">50% of patients</span> with long-standing diabetes. Conventional management focuses on pain suppression (gabapentinoids), but precision supplementation targets the underlying pathophysiology: oxidative stress and the polyol pathway.</p>

        <h3>Alpha-Lipoic Acid (ALA)</h3>
        <p>ALA is a unique "universal antioxidant" because it is both water and fat-soluble. In the <strong>SYDNEY 2 Trial</strong>, 600mg of ALA daily for 5 weeks significantly improved the Total Symptom Score (TSS), including stabbing pain, burning, and numbness. Mechanistically, ALA prevents the depletion of glutathione and improves endoneurial blood flow.</p>

        <h3>Benfotiamine: The Lipid-Soluble B1</h3>
        <p>Benfotiamine is a lipid-soluble derivative of Thiamine (B1). It activates the enzyme <strong>transketolase</strong>, which diverts toxic glucose metabolites away from the pathways that cause vascular and nerve damage. While standard Thiamine has poor bioavailability, Benfotiamine achieves <span class="stat-highlight">5x higher intracellular concentrations</span>.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study: Reversing Early Neuropathy</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Peripheral Nerve Health Intervention</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">üë®üèΩ</div>
                    <div class="patient-info">
                        <h4>Robert M., Age 58</h4>
                        <p>T2D (12 years), HbA1c 7.8%, presenting with "burning feet" and nocturnal tingling.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Robert was placed on the S.T.A.B.L.E. Method‚Ñ¢ nutrition plan (Module 2) combined with 600mg R-Alpha Lipoic Acid (TID) and 300mg Benfotiamine (BID).</p>
                <p><strong>Outcomes:</strong> After 12 weeks, Robert reported a <span class="stat-highlight">70% reduction in burning sensations</span>. His HbA1c dropped to 6.9%. Follow-up nerve conduction studies showed stabilized velocity, preventing further degradation.</p>
            </div>
        </div>

        <h2 id="magnesium">3. The Magnesium-Insulin Connection</h2>
        <p>Perhaps the most overlooked micronutrient in glycemic control is <span class="highlight">Magnesium</span>. Magnesium is a mandatory co-factor for over 300 enzymatic reactions, but its role in the <strong>Insulin Receptor Tyrosine Kinase</strong> activity is paramount for the Blood Sugar Coach.</p>

        <p>When insulin binds to its receptor, it triggers the autophosphorylation of tyrosine kinase. This process is <span class="highlight">magnesium-dependent</span>. If intracellular magnesium is low, the "lock and key" mechanism of insulin fails, leading to systemic insulin resistance. Data suggests that <span class="stat-highlight">25-38% of Type 2 diabetics</span> have clinical hypomagnesemia.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Form of Magnesium</th>
                        <th>Bioavailability</th>
                        <th>Primary Clinical Use</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Magnesium Glycinate</td>
                        <td>Very High</td>
                        <td>Insulin sensitivity, sleep, anxiety (high GI tolerance)</td>
                    </tr>
                    <tr>
                        <td>Magnesium Malate</td>
                        <td>High</td>
                        <td>ATP production, muscle fatigue, fibromyalgia</td>
                    </tr>
                    <tr>
                        <td>Magnesium Citrate</td>
                        <td>Moderate</td>
                        <td>Osmotic laxative, acute constipation</td>
                    </tr>
                    <tr>
                        <td>Magnesium Oxide</td>
                        <td>Very Low (4%)</td>
                        <td>General supplement (Poorly absorbed, avoid for T2D)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="pancreas">4. Pancreatic Synergy: D3, K2, and Zinc</h2>
        <p>While Berberine and Magnesium focus on peripheral sensitivity, the pancreatic islets require specific co-factors for the <strong>synthesis and secretion</strong> of insulin.</p>

        <ul>
            <li><strong>Vitamin D3:</strong> Pancreatic beta-cells express Vitamin D receptors (VDR). D3 modulates the inflammatory response within the islets and enhances insulin secretion. A 2023 meta-analysis found that D3 supplementation reduced the risk of progression from pre-diabetes to T2D by <span class="stat-highlight">15%</span>.</li>
            <li><strong>Vitamin K2 (MK-7):</strong> K2 activates osteocalcin, a bone-derived hormone that stimulates beta-cell proliferation and adiponectin expression (refer to Module 4: Adiponectin).</li>
            <li><strong>Zinc:</strong> Insulin is stored in the beta-cells as a <span class="highlight">zinc-insulin hexamer</span>. Zinc deficiency leads to impaired insulin crystallization and storage, resulting in "leaky" beta-cells and erratic glucose spikes.</li>
        </ul>

        <h2 id="interactions">5. Supplement-Drug Interactions & Safety</h2>
        <p>As a specialist, you must navigate the intersection of pharmacology and nutraceuticals. While we do not prescribe, we must screen for safety as part of the <strong>S: Screen & Assess</strong> phase of the S.T.A.B.L.E. Method‚Ñ¢.</p>

        <div class="alert-box warning">
            <span class="alert-label">Critical Safety Note</span>
            <p><strong>Metformin & Vitamin B12:</strong> Long-term Metformin use (over 6 months) is associated with a <span class="stat-highlight">30% reduction in B12 absorption</span>. Coaches must monitor for B12 deficiency symptoms (fatigue, cognitive fog) which can mimic diabetic neuropathy.</p>
        </div>

        <p><strong>SGLT2 Inhibitors & Ketoacidosis:</strong> Clients on SGLT2 inhibitors (e.g., Jardiance) should use caution with ultra-low-carb diets and high-dose ketones or Berberine, as this can theoretically increase the risk of euglycemic ketoacidosis (a rare but serious condition).</p>

        <h2 id="clinical">6. Clinical Application: The Precision Protocol</h2>
        <p>When applying these concepts, we follow a "Hierarchy of Need" approach. We don't start with 20 supplements; we layer them based on the client's specific metabolic phenotype identified in <strong>Module 1: Advanced Markers</strong>.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üî¨</div>
                <div>
                    <p class="box-label">Case Study: The Metabolic Synergy Approach</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Precision Glycemic Control</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">üë©üèº‚Äçüíº</div>
                    <div class="patient-info">
                        <h4>Elena S., Age 45</h4>
                        <p>PCOS, Insulin Resistance (HOMA-IR 4.2), struggling with "stubborn" weight.</p>
                    </div>
                </div>
                <p><strong>The Protocol:</strong> Rather than more Metformin, Elena's coach introduced 500mg Berberine Phytosome (BID) with her largest meals, 400mg Magnesium Glycinate at night, and 5000IU D3 + 100mcg K2.</p>
                <p><strong>Results:</strong> Within 8 weeks, Elena's fasting insulin dropped from 18 ŒºIU/mL to 9 ŒºIU/mL. Her HOMA-IR improved to <span class="stat-highlight">2.1</span>. She reported a total cessation of sugar cravings, which we attribute to the stabilization of the "AMPK-Hypothalamic" loop discussed in Lesson 8.2.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of micronutrient synergy.</p>

            <div class="question-item">
                <p class="question-text">1. Why is Berberine considered a "Metformin-mimetic"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Berberine activates the AMPK (Adenosine Monophosphate-activated Protein Kinase) pathway, which promotes GLUT4 translocation and insulin-independent glucose uptake, similar to Metformin's primary mechanism.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does Benfotiamine differ from standard Thiamine (B1) in treating neuropathy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Benfotiamine is lipid-soluble, allowing it to achieve significantly higher (up to 5x) intracellular concentrations than water-soluble Thiamine, making it more effective at activating transketolase to prevent vascular and nerve damage.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>AMPK Activation:</strong> Berberine is a potent metabolic regulator that rivals Metformin in clinical efficacy for HbA1c reduction.</li>
                <li><strong>The Neuropathy Duo:</strong> ALA and Benfotiamine target the oxidative and metabolic roots of nerve damage, not just the symptoms.</li>
                <li><strong>Magnesium is Mandatory:</strong> Without sufficient intracellular magnesium, the insulin receptor cannot properly signal (Tyrosine Kinase), leading to "locked" cells.</li>
                <li><strong>Beta-Cell Support:</strong> Zinc, D3, and K2 are essential for the structural integrity and secretion of insulin from the pancreas.</li>
                <li><strong>Safety First:</strong> Always screen for B12 deficiency in Metformin users and monitor for hypoglycemia when adding Berberine to existing medications.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight:600; color:#1e3a8a; margin-bottom:15px; text-transform:uppercase; letter-spacing:1px;">References & Further Reading</p>
            <ul style="list-style:none; padding:0; margin:0;">
                <li style="margin-bottom:10px;">Lan et al. (2014). "Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis." Journal of Ethnopharmacology.</li>
                <li style="margin-bottom:10px;">Ziegler et al. (2006). "Oral Treatment With Alpha-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy: The SYDNEY 2 Trial." Diabetes Care.</li>
                <li style="margin-bottom:10px;">Kostov, K. (2019). "Effects of Magnesium Deficiency on Type 2 Diabetes Mellitus." Nutrients.</li>
                <li style="margin-bottom:10px;">Pittas et al. (2023). "Vitamin D and Risk for Type 2 Diabetes in People with Pre-diabetes: A Systematic Review and Meta-analysis." Annals of Internal Medicine.</li>
                <li style="margin-bottom:10px;">Hamid et al. (2011). "The Role of Zinc in Insulin Secretion and Action." Journal of Trace Elements in Medicine and Biology.</li>
                <li style="margin-bottom:10px;">Ametov et al. (2003). "The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With Alpha-Lipoic Acid: The SYDNEY Trial." Diabetes Care.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Proprietary S.T.A.B.L.E. Method‚Ñ¢ Framework.</p>
        </footer>
    </div>

    <script>
        // Simple script for the reveal button functionality
        document.querySelectorAll('.reveal-btn').forEach(button => {
            button.addEventListener('click', function() {
                const answer = this.nextElementSibling;
                if (answer.style.display === 'block') {
                    answer.style.display = 'none';
                } else {
                    answer.style.display = 'block';
                }
            });
        });
    </script>
</body>

</html>